P Kaitlyn Edelson1, Sarah N Bernstein2. 1. Department of Obstetrics and Gynecology Founders 4, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. pkedelson@mgh.harvard.edu. 2. Department of Obstetrics and Gynecology Founders 4, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.
Abstract
PURPOSE OF REVIEW: Substance use disorder in pregnancy and subsequent cardiovascular complications are on the rise in the USA. The care of pregnant women with substance use disorder is complex, and requires a thorough understanding of mechanisms of action, pathophysiology, and cardiovascular response during pregnancy. The goal of this review is to provide information about the most common drugs of abuse in pregnancy and to recommend management guidelines. RECENT FINDINGS: Pregnant women with substance use disorder are at increased risk of significant cardiovascular complications, both as a direct effect of acute intoxication as well as the secondary risk from infection and cardiotoxicity associated with chronic use. This risk must be considered in the antepartum management, delivery, and postpartum periods. Understanding the increased cardiovascular risk of pregnant women with substance use disorder, as well as specific drug interactions, anesthesia considerations, best practices, and management considerations, is important for all clinicians caring for this population.
PURPOSE OF REVIEW: Substance use disorder in pregnancy and subsequent cardiovascular complications are on the rise in the USA. The care of pregnant women with substance use disorder is complex, and requires a thorough understanding of mechanisms of action, pathophysiology, and cardiovascular response during pregnancy. The goal of this review is to provide information about the most common drugs of abuse in pregnancy and to recommend management guidelines. RECENT FINDINGS: Pregnant women with substance use disorder are at increased risk of significant cardiovascular complications, both as a direct effect of acute intoxication as well as the secondary risk from infection and cardiotoxicity associated with chronic use. This risk must be considered in the antepartum management, delivery, and postpartum periods. Understanding the increased cardiovascular risk of pregnant women with substance use disorder, as well as specific drug interactions, anesthesia considerations, best practices, and management considerations, is important for all clinicians caring for this population.
Entities:
Keywords:
Cardiac disease in pregnancy; Obstetrics; Pregnancy; Substance use disorder
Authors: O Fajemirokun-Odudeyi; C Sinha; S Tutty; P Pairaudeau; D Armstrong; T Phillips; S W Lindow Journal: Eur J Obstet Gynecol Reprod Biol Date: 2005-10-03 Impact factor: 2.435
Authors: João Victor Vezali Costardi; Rafael Augusto Teruaki Nampo; Gabriella Lourenço Silva; Maria Aparecida Ferreira Ribeiro; Heryck José Stella; Mercia Breda Stella; Sônia Valéria Pinheiro Malheiros Journal: Rev Assoc Med Bras (1992) Date: 2015-08 Impact factor: 1.209
Authors: Ana M Tobiasz; Jose R Duncan; Zoran Bursac; Ryan D Sullivan; Danielle L Tate; Alex M Dopico; Anna N Bukiya; Giancarlo Mari Journal: Reprod Sci Date: 2017-10-05 Impact factor: 3.060
Authors: Sarah C Haight; Jean Y Ko; Van T Tong; Michele K Bohm; William M Callaghan Journal: MMWR Morb Mortal Wkly Rep Date: 2018-08-10 Impact factor: 17.586
Authors: Natasia S Courchesne; Laramie R Smith; María Luisa Zúñiga; Christina D Chambers; Mark B Reed; Jerasimos Ballas; Carla B Marienfeld Journal: Alcohol Clin Exp Res Date: 2021-09-19 Impact factor: 3.455